Fuke, Toshiya <br/><br/>
Mizoribine requires individual dosing due to variation of bioavailability.  [electronic resource] 

 -  Pediatrics international : official journal of the Japan Pediatric Society  Dec 2012 
 - 885-91 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1442-200X 
<br/><br/><label>Standard No.: </label>10.1111/j.1442-200X.2012.03733.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Biological Availability<br/>Child<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Lupus Nephritis--blood<br/>Male<br/>Retrospective Studies<br/>Ribonucleosides--administration & dosage<br/>Treatment Outcome